Endocrine Flashcards

1
Q

MEN 1

A

Parathyroid, Pituitary adenoma, Pancreatic (insulin, gastrin, VIP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MEN 2A

A

Parathyroid, Medullary thyroid Ca, Pheo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MEN 2B

A

Marfanoid, Medullary thryroid Ca, Pheo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Thyroid Storm Tx

A
  • ABCs
  • Supportive care
  • Beta-blockers (careful with hemodynamic status!)
  • E.g. Propranolol 60-80mg PO q4-6h
  • PTU (usually 200 mg PO q4h) THEN 1 hr later
  • Lugol’s iodine 10 drops q8h
  • Glucocorticoids (often AI co-exists, also helps to reduce fT4 to fT3 conversion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TSH target during pregnancy

A

TSH <2.5

  • Remember to if TSH >2.5 with positive TPO Ab—>Tx
    if TSH 4.0-10 with negative TPO —>Consider Tx
    If TSH >10 with negative TPO—> Defs Tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypothyroidism in pregnancy, how much should synthroid dose be increased by?

A

20-30%, extra pill Saturday and Sunday.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Graves in pregnancy, what therapy should you use for first trimester? Beyond?

A

1st trimester= PTU

beyond=MMZ at lowest dose possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indications for statin initiation with DM?

A
  • Clinical CVD
  • Age ≥ 40
  • Age >30 and diabetes duration > 15 years
  • Microvascular disease
  • Other CV risk factors

If LDL not in target can use ezetimibe or evolocumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Indications for ACE/ARB initiation with DM?

A
  • Clinical CVD
  • Age ≥ 55 with an additional CV risk factor or end organ damage (albuminuria, retinopathy, LVH)
  • Microvascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define Primary Amenorrhea

A
  • Absent menses at age 16

* Absent sexual characteristics at age 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define Secondary Amenorrhea

A

Definition: No cycles for >3 months in those with regular periods, or >6 months in those with irregular periods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PCOS diagnosis criteria

A

2 of:
• Menstrual irregularity
• Biochemical or clinical hyperandrogenism
• Ultrasound findings of polycystic ovaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

++ Symptoms, not very high prolactin = what effect?

A

++ Symptoms, not very high prolactin?

• Hook effect – lab peculiarity where very high levels of prolactin are read as low levels. If you dilute the sample, you can get a more accurate reading

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

++ Prolactin, not very many symptoms, caused by what phenomenon?

A

++ Prolactin, not very many symptoms
• Macroprolactin – a type of prolactin multimer which is biologically inactive. It can be in the serum in very high levels and cause no symptoms. It only sticks around because its clearance is slow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

High risk sonographic features of thyroid nodule?

A

– Hypoechoic
– Irregular margins – Microcalcifications – Taller than wide
– Extrathyroidal extension
– Interrupted rim calcifications – Lymphadenopathy
– >20% increase in 2 dimensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Who needs Bx of thyroid nodule? (based on US features)

A
  1. High/Intermediate suspicion sonographic features:>1cm
  2. Low suspicion sonographic features:>1.5cm
  3. Could consider:Very low suspicion>2cm
  4. Do not biopsy:Purely cystic nodules
17
Q

Diagnosis of DM (HgA1c, Fasting, 75 OGTT)

A
• Fasting glucose >= 7mmol/L
• HbA1c >=6.5%
• 2h 75g OGTT >=11.1 mmol/L
• Random BG >=11.1 mmol/L
(IFG: 6.1-6.9) (Pre diabetes: 6.0-6.4%)
18
Q

Who needs FASTING lipid profile?

A

History of TG> 4.5 mmol/L
DIABETES
CKD

19
Q

Lipid targets for treatment?

A

Target
LDL-C <2 mmol/L or >50% ↓ or
Non-HDL-C <2.6 mmol/L or
Apo B <0.8 g/L or

Note1: LDL>5 … 1o target is >50% ↓
Note2: If recent MI more aggressive consider target LDL <1.8 based upon IMPROVE-IT.

20
Q

How does hypomagnesium affect the ability to correct hypocalcemia?

A

Magnesium deficiency reduces PTH secretion and causes PTH resistance. Therefore think of hypomagnesemia in someone with apparent hypoparathyroidism.

21
Q

DDX for high RAIU (>25%) and low RAIU?

A
High= endogenous uptake (think PET SCAN). Therefore, Graves or toxic multinodular goiter
Low= increased thyroid hormone but not increased production. ie. leak. Ex. Thyroiditis
22
Q

What causes a falsely low RAIU? Ie. Graves disease but RAIU is low instead of high.

A

Ø CT scan (iodinated contrast)
Ø Amiodarone (iodine load)
Ø Iodine intake (e.g. kelp)

23
Q

Should always use MMZ over PTU for treatment of hyperthyroidism (less hepatotoxicity). What are 3 instances that you would use PTU over MMZ?

A

Ø Pregnancy (risk of aplasia cutis & cleft palate)- Defs use PTU for T1, can switch to MMZ thereafter
Ø Thyroid storm
Ø Minor MMZ reactions (if severe, then shouldn’t use anti-thyroid drugs at all)

24
Q

Sub-clinical hypothyroidism is defined at TSH up to 10 without changes to fT4. Treatment is indicated if TSH>10 or…

A

Ø Symptomatic
Ø Goiter
Ø Pregnant/pregnancy-planning
Ø Positive anti-TPO antibodies

25
Q

What is Romosuzumab?

A

Used in Osteoporosis treatment:
• Monoclonal anti-sclerostin antibody
• Sclerostin is produced by osteocytes and
inhibits bone formation.
• SC injection given monthly for 12 months

26
Q

Best treatment for glucocorticoid induced osteoporosis?

A

Teriparatide

27
Q

Drug doses for Ca + Vit D in OP?

A

Vitamin D 800-2000IU/day (if age>50) OR 400– 1000 IU/day (if age < 50 and low risk of deficiency).
• Target 25-OH vitamin D level≥75nmol/L
• Aim for total calcium intake of 1200mg/day

28
Q

Benefits of switching from BBIT to pump therapy

A
  1. Less hypoglycemia
  2. Improved QOL
  3. Modest decrease in A1c
29
Q

Anti-hyperglycemics with CVD benefit?

A

Empagliflozin
Canaglaflozin
Liraglutide- +wt loss
Semaglutide- worsens retinopathy

Dapgliflozin–>reduced hospitalizations due to heart failure but no mortaligty benefit

30
Q

Side effects of Cana and Empagliflozin? Which one has higher risk of toe amputations?

A

Risk of euglycemic DKA
Possible perineal necrotizing fasciitis
GU infections

+ Toe amputations with Cana